p53 Codon 72 arginine/proline polymorphism and cancer in Sudan

被引:18
|
作者
Eltahir, Huda A. [1 ]
Adam, Ameera A. M. [1 ]
Yahia, Zeinab A. [1 ]
Ali, Noon F. [1 ]
Mursi, Dalia M. [1 ]
Higazi, Ashraaf M. [1 ]
Eid, Nahid A. [1 ]
Elhassan, Ahmed M. [1 ]
Mohammed, Hiba S. [1 ]
Ibrahim, Muntaser E. [1 ]
机构
[1] Univ Khartoum, Dept Mol Biol, Inst Endem Dis, Khartoum 102, Sudan
关键词
P53 arg/pro polymorphism-Sudan-cancers; CERVICAL-CANCER; RISK; GENOTYPES; TP53;
D O I
10.1007/s11033-012-1978-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this report is to determine frequencies and associations of p53 codon 72 arg/pro polymorphism with different types of cancer in Sudan. p53 codon72 arg/pro polymorphism distribution and allele frequencies in 264 samples of different types of cancers were investigated using PCR. The results were compared to 235 normal controls. The results indicated significant differences in frequency and genotype association between different types of cancers. Breast carcinoma patients most prominently showed excess of homozygous arg genotype as compared to controls with an Odd ratio (OR) of 19.44, 95 %CI: 6.6-78.3, P < 0.0001. Less prominently cervical cancer showed genotype effect of 2.4 OR, 95 %CI: 1.12-5.33, P = 0.015, while esophageal cancer had an OR of 0.57, 95 %CI: 0.23-1.42, P = 0.1. In Burkitt's lymphoma, however, in contrast the homozygous arg accounted for only 6.9 %, (OR 0.18, 95 %CI: 0.02-0.89, P = 0.018). We concluded that p53 arg/pro polymorphism has different pattern of frequency in different types of cancer among Sudanese patients, indicating perhaps different etiology and biology of these tumours.
引用
收藏
页码:10833 / 10836
页数:4
相关论文
共 50 条
  • [1] p53 Codon 72 arginine/proline polymorphism and cancer in Sudan
    Huda A. Eltahir
    Ameera A. M. Adam
    Zeinab A. Yahia
    Noon F. Ali
    Dalia M. Mursi
    Ashraaf M. Higazi
    Nahid A. Eid
    Ahmed M. Elhassan
    Hiba S. Mohammed
    Muntaser E. Ibrahim
    [J]. Molecular Biology Reports, 2012, 39 : 10833 - 10836
  • [2] p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases
    Chen, Rong-Hsing
    Chang, Chwen-Tzuei
    Wang, Tzu-Yuan
    Huang, Wen-Liang
    Tsai, Chang-Hai
    Tsai, Fuu-Jen
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2008, 22 (05) : 321 - 326
  • [3] Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine/proline polymorphism
    Tachezy, R
    Mikysková, I
    Saláková, M
    Van Ranst, M
    [J]. HUMAN GENETICS, 1999, 105 (06) : 564 - 566
  • [4] Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine/proline polymorphism
    Tachezy R.
    Mikyšková I.
    Saláková M.
    Van Ranst M.
    [J]. Human Genetics, 1999, 105 (6) : 564 - 566
  • [5] The proline form of p53 codon 72 polymorphism is associated with endometriosis
    Chang, CC
    Hsieh, YY
    Tsai, FJ
    Tsai, CH
    Tsai, HD
    Lin, CC
    [J]. FERTILITY AND STERILITY, 2002, 77 (01) : 43 - 45
  • [6] P53 codon 72 polymorphism in breast cancer
    Buyru, N
    Tigli, H
    Dalay, N
    [J]. ONCOLOGY REPORTS, 2003, 10 (03) : 711 - 714
  • [7] Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: p53 with arginine at codon 72 favors apoptosis
    Jeong, Byeong-Seon
    Hu, Wenwei
    Belyi, Vladimir
    Rabadan, Raul
    Levine, Arnold J.
    [J]. FASEB JOURNAL, 2010, 24 (05): : 1347 - 1353
  • [8] Germline polymorphism of p53 codon 72 in gynecological cancer
    Ueda, M
    Terai, Y
    Kanda, K
    Kanemura, M
    Takehara, M
    Yamaguchi, H
    Nishiyama, K
    Yasuda, M
    Ueki, M
    [J]. GYNECOLOGIC ONCOLOGY, 2006, 100 (01) : 173 - 178
  • [9] p53 codon 72 polymorphism and risk of cervical cancer
    Ojeda, JM
    Ampuero, S
    Rojas, P
    Prado, R
    Allende, JE
    Barton, SA
    Chakraborty, R
    Rothhammer, F
    [J]. BIOLOGICAL RESEARCH, 2003, 36 (02) : 279 - 283
  • [10] p53 codon 72 polymorphism and urothelial cancer risk
    Kuroda, Y
    Tsukino, H
    Nakao, H
    Imai, H
    Katoh, T
    [J]. CANCER LETTERS, 2003, 189 (01) : 77 - 83